Pacira Pharmaceuticals reported $39.79M in Pre-Tax Profit for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Pre Tax Profit Change
Acelrx Pharmaceuticals ACRX:US $ -8.67M 0.76M
Amerisourcebergen ABC:US $ 867.38M 171.74M
Astellas Pharma 4503:JP Y -10516M 88833M
Bristol Myers Squibb BMY:US $ 5386M 595M
Cara Therapeutics CARA:US $ -27749000 5.63M
Coherus Biosciences CHRS:US $ -96.08M 50.36M
Heron Therapeutics HRTX:US $ -63.89M 9.24M
JAZZ PHA JAZZ:US $ 321.29M 19.04M
Johnson & Johnson JNJ:US $ 8218M 1879M
Nektar Therapeutics NKTR:US $ -90.27M 55.38M
Omeros OMER:US $ -39494000 7.82M
Pacira Pharmaceuticals PCRX:US $ 39.79M 19.7M
Pfizer PFE:US $ 11328M 4083M
Revance Therapeutics RVNC:US $ -64.34M 1.24M
Supernus Pharmaceuticals SUPN:US $ 14.72M 12.67M
Teva Pharmaceutical TEVA:IT -971000000 796M
Xeris Pharmaceuticals Inc XERS:US $ -34122000 16.67M
Xoma XOMA:US $ -2.28M 32.22M
Zoetis ZTS:US $ 769M 188M